- « Previous
- Clinical Pharmacology
- Next »
Paraplatin
Clinical Pharmacology
Clinical Pharmacology
Paraplatin
Use as a Single Agent for Secondary Treatment of Advanced Ovarian Cancer: In two prospective, randomized controlled studies in patients with advanced ovarian cancer previously treated with chemotherapy, carboplatin achieved six clinical complete responses in 47 patients. The duration of these responses ranged from 45 to 71+ weeks.
Brand Name: Paraplatin
Generic Name: Carboplatin
Generic Name: Carboplatin
- « Previous
- Clinical Pharmacology
- Next »
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.
WebMD Resources
Cancer and Exercise
Resting to conserve energy may not be the best remedy for fatigue during radiation therapy. See more WebMD Videos »
